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potential in Swiss albino mice and in vitro
thrombolytic activity of hydroalcoholic
extract from Litsea glutinosa leaves
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Background: The study was conducted to evaluate the in vitro thrombolytic activity, and in vivo analgesic,
anti-inflammatory and antipyretic potentials of different hydrocarbon soluble extracts of Litsea glutinosa leaves for
the first time widely used in the folkloric treatments in Bangladesh. This work aimed to create new insights on the
fundamental mechanisms of the plant extracts involved in these activities.
Results: In thrombolytic activity assay, a significant clot disruption was observed at dose of 1 mg/mL for each of
the extracts (volume 100 μL) when compared to the standard drug streptokinase. The n-hexane, ethyl acetate,
chloroform, and crude methanolic extracts showed 32.23 ± 0.26, 37.67 ± 1.31, 43.13 ± 0.85, and 46.78 ± 0.9% clot
lysis, respectively, whereas the positive control streptokinase showed 93.35 ± 0.35% disruption at the dose of
30,000 I.U. In hot plate method, the highest pain inhibitory activity was found at a dose of 500 mg/kg of crude
extract (15.54 ± 0.37 sec) which differed significantly (P <0.01 and P <0.001) with that of the standard drug
ketorolac (16.38 ± 0.27 sec). In acetic acid induced writhing test, the crude methanolic extract showed significant
(P <0.01 and P <0.001) analgesic potential at doses 250 and 500 mg/kg body weight (45.98 and 56.32%
inhibition, respectively), where ketorolac showed 64.36% inhibition. In anti-inflammatory activity test, the crude
methanolic extract showed significant (P <0.001) potential at doses 250 and 500 mg/kg body weight (1.51 ± 0.04
and 1.47 ± 0.03 mm paw edema, respectively), where ketorolac showed 1.64 ± 0.05 mm edema after 3 h of
carrageenan injection. In antipyretic activity assay, the crude extract showed notable reduction in body
temperature (32.78 ± 0.46°C) at dose of 500 mg/kg-body weight, when the standard (at dose 150 mg/kg-body
weight) exerted 33.32 ± 0.67°C temperature after 3 h of administration.
Conclusions: Our results yield that the crude hydroalcoholic extract has better effects than the other in all trials.
In the context, it can be said that the leaves of L. glutinosa possess remarkable pharmacological effects, and
justify its traditional use as analgesic, antipyretic, anti-inflammatory, and thrombolytic agent.
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Traditional knowledge regarding medicinal plants and
their use by indigenous cultures is not only useful for
maintenance of cultural traditions and biodiversity but
also for community healthcare and drug development in
the present and future. Therapies with synthetic tropical
applications have many side effects and cannot be afforded
by the people due to higher cost of the drug. For overcom-
ing this problem plants growing around us are utilized
without scientific validation. The use of higher plants and
their extracts to treat infections is an age-old practice.
Traditional medicinal practice has been known for centur-
ies in many parts of the world. Herbal medicines are gain-
ing interest because of their cost effective and eco-friendly
attributes [1].
L. glutinosa belongs to the family Lauraceae and is a
well-known evergreen species growing wild in the forest
of Chittagong and Sylhet districts in Bangladesh. It is oc-
casionally planted in most areas of the country [2]. Leaves
are mucilaginous and considered for antispasmodic, emol-
lient, and poultice. The leaves are also used in diarrhea
and dysentery as well as for the treatment of wounds and
bruises [2]. The leaves were reported for the treatment of
the spontaneous and excessive flow of semen in young
boys [3]. The leaf extract also shows antibacterial and car-
diovascular activities [4]. The berries yield oil which is used
by some tribal practitioners in the treatment of rheuma-
tism. Tannin, β-sitosterol, and actinodaphnine are reported
to be the common constituents of the species; and other
constituents known are: Boldine, norboldine, laurotetanine,
n-methyllaurotetanine, n-methylactinodaphnine, quercetin,
sebiferine, litseferine etc. [5].
Thrombosis is the fundamental pathophysiological
process that underlies the acute coronary disorders such
as pulmonary emboli, deep vein thrombosis, strokes and
heart attacks; which are the main causes of morbidity and
mortality in developed countries [6]. This disease is char-
acterized by the development of a blood clot (thrombus)
in the circulatory system of the body due to the failure of
homeostasis which leads to vascular blockade and while
recovering causes fatal consequences, such as myocardial
or cerebral infarction, as well as death [7]. Therefore,
anticoagulation therapy is the basis of management, and
the proper choice of thrombolytic drugs [8].
Pain is an unpleasant sensory and emotional experience
associated with actual or potential tissue damage [9]. By
acting in the CNS or on the peripheral pain mechanism,
analgesic compounds selectively relieves pain without sig-
nificant alteration of consciousness. Actually analgesics
are applied when the noxious stimulus cannot be removed
or as adjuvant to more etiological approach to pain [10].
Inflammation is the response of living tissues to injury.
It involves a complex array of enzyme activation, mediator
release, and extravasations of fluid, cell migration, tissuebreakdown and repair. Non-steroidal anti-inflammatory
drugs (NSAID) are among the most commonly prescribed
drugs due to their consistent effectiveness in the treatment
of pain, fever, inflammation and rheumatic disorders.
However, their use is associated with adverse effects at the
level of digestive tract, ranging from dyspeptic symptoms,
gastrointestinal erosions and peptic ulcers to more serious
complications, such as over bleeding or perforation [11].
Therefore to overcome the toxicity of NSAID, the devel-
opment of new anti-inflammatory drugs is still necessary
and the natural product such as medicinal plants could
lead in discovering new anti-inflammatory drugs with less
undesirable effects [12].
Pyrexia or fever is usually caused as a secondary impact
of infection, tissue damage, inflammation, graft rejection
and malignancy or other diseased states. The body by its
natural defense mechanism creates an environment where
infectious agent or damaged tissue cannot survive. Gener-
ally, infected or damaged tissue initiates the enhanced for-
mation of pro-inflammatory mediators (cytokines like
interleukin 1β, α, β and TNF-α) which increase the syn-
thesis of prostaglandin E2 (PGE2) near preoptic hypothal-
amus area and thereby triggering the hypothalamus to
elevate the body temperature [13]. Most of the antipyretic
drugs normally prevent or inhibit COX-2 expression to re-
duce the elevated body temperature by inhibiting PGE2
biosynthesis. Moreover, these synthetic agents irreversibly
inhibit COX-2 with high selectivity which is toxic to the
hepatic cells, glomeruli, cortex of brain and heart muscles,
whereas natural COX-2 inhibitors usually have lower se-
lectivity with fewer side effects [14]. L. glutinosa was se-
lected due to its availability in Bangladesh, therefore, used
in rural areas for different treatments, and not such inves-
tigations have been carried out with this plant native to
Bangladesh. Our main goal was to evaluate the in vivo
antipyretic, anti-inflammatory and analgesic activity, and
investigate the thrombolytic property of the plant leaves to
validate its traditional uses.
Results
Thrombolytic activity test
The effective clot lysis percentage by four different ex-
tracts of the plant, positive thrombolytic control (Strepto-
kinase) and negative control (water) is tabulated in
Figure 1. From the Figure 1, it is evident that the percent-
age of clot lysis was 93.35 ± 0.35% when 100 μl of strepto-
kinase (30,000 I.U.) was used as a positive control, while
in case of negative control (water) the percentage of clot
lysis was negligible (7.06 ± 0.95%). Among different ex-
tracts (concentration 1 mg/ml), the crude methanolic
extract showed highest activity (46.78 ± 0.90%), whereas
n-hexane soluble fraction showed the lowest activity
(32.23 ± 0.26%), which was much higher than the nega-
tive control (water).
Figure 1 Thrombolytic effect of hydroalcoholic extracts of
L. glutinosa leaves.
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Hot plate test
Two doses of methanolic extract of leaves of L. glutinosa
increased the animal (Swiss-albino mice) reaction time
to the thermal stimulus which has been summarized in
Table 1. The highest pain inhibition of thermal stimulus
was found at a higher dose 500 mg/kg of crude extract
which exhibited maximum time for the response against
thermal stimuli (15.54 ± 0.37 sec) that is comparable to
ketorolac (16.38 ± 0.27 sec) and found statistically signifi-
cant (P <0.001 and P <0.01) when compared to both the
control and the standard drug.
Acetic acid induced writhing test
The effect of the methanolic extract of L. glutinosa leaves
on acetic acid induced writhing in mice is given in Table 2.
At the dose of 500 mg/kg of body weight, the crude ex-
tract produced 56.32% writhing inhibition in test animals.Table 1 Effect of hydroalcholic extracts of L. glutinosa leaves
Treatment
0 h 0.5 h
Control (10 ml/kg) 8.30 ± 0.63 7.42 ± 0.42
Standard (10 mg/kg) 8.42 ± 0.29 11.59 ± 0.32**
n-hexane extract (250 mg/kg) 8.27 ± 0.32 10.25 ± 0.31**c
n-hexane extract (500 mg/kg) 8.57 ± 0.63 11.01 ± 0.66**
Ethyl acetate extract (250 mg/kg) 8.73 ± 0.30 10.05 ± 0.32**a
Ethyl acetate extract (500 mg/kg) 8.70 ± 0.56 10.87 ± 0.46
chloroform extract (250 mg/kg) 8.90 ± 0.40 10.58 ± 0.29***
chloroform extract (500 mg/kg) 8.87 ± 0.15 11.16 ± 0.47**
Methanolic extract (250 mg/kg) 9.10 ± 0.33 11.48 ± 0.63**
Methanolic extract (500 mg/kg) 8.82 ± 0.18 11.54 ± 0.52**
Values are expressed as mean ± SEM (Standard error mean); Values are calculated u
**indicates P <0.01 when compared to control; aindicates P <0.001, bindicates P <0.0The results were statistically significant (P <0.001) com-
pared to the negative control.
Anti-inflammatory activity test
The anti-inflammatory effect of the crude methanolic
extract using carrageenan induced oedema tests is
expressed in Table 3. In this test, the positive control
(ketorolac) significantly (P <0.05; P <0.001) decreased
the paw edema volume, 0.96 ± 0.05 to 1.64 ± 0.05 mm, at
1 to 3 h after carrageenan injection compared to control
(saline) with edema volume. A maximum edema paw
volume of 1.78 ± 0.03 mm was observed in the control
mice, after 3 h of the carrageenan injection. Mice adminis-
tered with extract at 500 mg/kg body weight significantly
decreased (P <0.05; P <0.01) the carrageenan-induced
edema paw volume from 1 to 3 h compared to the control
(saline) at a dose of 2 ml/kg body weight. The highest
reduction in the paw volume by the 500 mg/kg body
weight was 1.47 ± 0.03 mm when compared to that of the
control (saline) (1.78 ± 0.03 mm) at 3 h.
Antipyretic activity test
Effect of different extracts of L. glutinosa on rectal
temperature in mice is presented in Table 4. The subcuta-
neous injection of yeast suspension markedly elevated
the rectal temperature after 18 h of administration.
Treatment with the crude methanolic extract showed
significant (P <0.05; P <0.001) activity against induced
pyrexia when compared with the control treatment.
Discussion
Thrombosis or blood clot formation is a critical event in
which the damaged regions of the endothelial cell surface
or blood vessel are blocked by the deposition of platelets,
tissue factor and fibrin [15]. In the formation process the
major role is played by platelets as the process ofon hot plate test
Response time (sec)
1 h 2 h 3 h
7.50 ± 0.39 7.50 ± 0.45 7.18 ± 0.33
13.58 ± 0.38** 14.98 ± 0.48*** 16.38 ± 0.27***
10.94 ± 0.13***a 11.27 ± 0.58**a 11.98 ± 0.37***b
11.43 ± 0.25***b 11.59 ± 0.76**b 12.22 ± 0.48***a
10.30 ± 0.74**a 11.13 ± 0.47**b 11.39 ± 0.65**b
11.36 ± 0.27***b 11.48 ± 0.59**b 11.89 ± 0.63**b
c 11.03 ± 0.40**b 11.33 ± 0.66*b 12.07 ± 0.28***a
11.49 ± 0.24***b 11.69 ± 0.78**b 12.31 ± 0.54***b
13.20 ± 0.38** 14.24 ± 0.42*** 15.06 ± 0.36***
13.38 ± 0.44** 14.56 ± 0.49*** 15.54 ± 0.37***b
sing one-way ANOVA followed by Dennett’s test; ***indicates P <0.001 and
1 and cindicates P <0.05 when compared to standard drug; p.o.; n = 6.
Table 2 Effect of hydroalcholic extracts of L. glutinosa
leaves on acetic acid induced writhing in mice
Treatment Total writhing count
(Mean ± SEM)
% Inhibition
Control 17.4 ± 2.50 -
Standard 6.2 ± 0.66*** 64.36
n-hexane extract (250 mg/kg) 10.10 ± 0.41** 41.95
n-hexane extract (500 mg/kg) 8.7 ± 0.57*** 50.00
Ethyl acetate extract (250 mg/kg) 10.14 ± 0.63** 41.72
Ethyl acetate extract (500 mg/kg) 9.96 ± 0.29** 42.76
Chloroform extract (250 mg/kg) 11.6 ± 0.31** 33.33
Chloroform extract (500 mg/kg) 9.15 ± 0.36** 47.41
Methanolic extract (250 mg/kg) 9.40 ± 0.51** 45.98
Methanolic extract (500 mg/kg) 7.60 ± 0.51*** 56.32
Values are expressed as mean± SEM (Standard error mean); ***indicates P <0.001,
and **indicates P <0.01; one-way ANOVA followed by Dennett’s test as compared
to control.
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platelets to platelets bonds. These activated platelets fur-
ther bind to the leucocytes and bring them into a complex
process of plaque formation and growth [16]. It is the
thrombolytic agents that lyse clot by disrupting the fi-
brinogen and fibrin contained in a clot. Plasmin is one of
the natural anti-thrombotic agents. The cell surface bound
plasminogen is easily activated to plasmin which ultim-
ately leads to fibrinolysis [17]. After a long process of trial
and error the scientists have discovered several thrombo-
lytic drugs from various sources. To make those drugs
more site specific and effective some of them have been
modified with modern recombinant technology. Strepto-
kinase (a bacterial plasminogen activator), a widely used
thrombolytic agent, is capable of converting additional
plasminogen to plasmin. But this drug has several adverse
effects like bleeding and embolism which lead to furtherTable 3 Anti-inflammatory activity of hydroalcholic extracts o
Treatments
0 h
Control 0.73 ± 0.04
Standard 0.69 ± 0.04
n-hexane extract (250 mg/kg) 0.90 ± 0.14
n-hexane extract (500 mg/kg) 0.71 ± 0.05
Ethyl acetate extract (250 mg/kg) 0.91 ± 0.11
Ethyl acetate extract (500 mg/kg) 0.88 ± 0.02
Chloroform extract (250 mg/kg) 0.81 ± 0.04
Chloroform extract (500 mg/kg) 0.69 ± 0.08
Methanolic extract (250 mg/kg) 0.77 ± 0.04
Methanolic extract (500 mg/kg) 0.69 ± 0.05
Values are expressed as mean ± SEM (Standard error mean); Values are calculated a
**indicates P <0.05; ***indicates P <0.001 vs. control; n = 5.complications. To overcome these complications a num-
ber of studies have been conducted by various researchers
in order to discover new sources of herbs and natural
foods and their supplements having antithrombotic effect
with minimal adverse effect [6]. As a part of that research
work we also tried to find whether the herbal preparations
of L. glutinosa leaves possess clot lysis potentiality or not.
When we compared the result of positive control (strepto-
kinase) with that of negative control (water), we found that
there was negligible amount of clot disruption when water
was added to the clot. This prominent result encouraged
us to compare four different test samples in the same
manner against the negative control and observe sig-
nificant thrombolytic activity. It was reported that phy-
tochemicals like saponin, alkaloids and tannin are
responsible for thrombolytic activity [18]. As the bark
extract of L. glutinosa possesses saponin, alkaloids [19],
therefore the possibility of the presence of these phyto-
chemicals in the leaves extract may be the probable
reason of demonstrating the thrombolytic activity.
It was observed from the study that in both analgesic
activity assay models the plant extract demonstrated
analgesic effects. This means that the extract may pos-
sess both peripheral and central analgesic effects. The
leaves extract of L. glutinosa exhibited significant dose
dependent inhibition of acetic acid‑induced writhing in
mice in comparison to that of the control (saline).
Acetic acid induces inflammatory pain by impelling
capillary permeability [20], and releasing substances
that excite pain nerve endings [21]. The peripheral
analgesic effect is generally mediated by the NSAIDs
through inhibition of cyclooxygenase and/or lipoxy-
genase (and other inflammatory mediators) or inhib-
ition of pain responses mediated by noiceptors
peripherally [22]. Therefore, it is possible that crude
extract of L. glutinosa leaves may be showing analgesicf leaves of L. glutinosa
Paw volume (mm)
1 h 2 h 3 h
1.31 ± 0.19 1.58 ± 0.02 1.78 ± 0.03
0.96 ± 0.05** 1.34 ± 0.05*** 1.64 ± 0.05***
1.91 ± 0.04** 2.02 ± 0.04** 2.19 ± 0.03***
1.60 ± 0.02** 1.98 ± 0.13** 2.17 ± 0.04***
1.11 ± 0.05** 1.51 ± 0.03*** 1.32 ± 0.03**
1.41 ± 0.07** 1.63 ± 0.10** 1.77 ± 0.02***
1.21 ± 0.06** 1.42 ± 0.02** 1.59 ± 0.01***
1.00 ± 0.03** 1.40 ± 0.06** 1.47 ± 0.03***
1.01 ± 0.04** 1.42 ± 0.03** 1.51 ± 0.04***
1.00 ± 0.04** 1.40 ± 0.03** 1.47 ± 0.03***
s compared to control using one way-ANOVA followed by Dunnet’s Test;
Table 4 Effect of the hydroalcholic extracts of L. glutinosa on yeast-induced pyrexia in mice
Treatment Initial Pyretic 1 h 2 h 3 h
Control (10 ml/kg) 33.33 ± 0.44 35.70 ± 0.46 35.66 ± 0.44 35.77 ± 0.56 35.39 ± 0.66
Standard (150 mg/kg) 33.28 ± 0.42 35.73 ± 0.55 34.80 ± 0.68 34.20 ± 0.63** 33.32 ± 0.67***
n-hexane extract (500 mg/kg) 33.80 ± 0.30 36.17 ± 0.40 35.90 ± 0.46 35.77 ± 0.25c 35.60 ± 0.17b
Ethyl acetate extract (500 mg/kg) 33.69 ± 0.79 35.57 ± 0.25 35.27 ± 0.15 35.00 ± 0.36* 34.87 ± 0.32c
Chloroform extract (500 mg/kg) 33.43 ± 1.37 35.37 ± 0.60 35.45 ± 0.70 35.23 ± 0.21c 35.17 ± 0.32b
Methanolic extract (500 mg/kg) 33.64 ± 0.80 36.93 ± 0.54 36.26 ± 0.68*c 34.13 ± 0.54** 32.78 ± 0.46***
Values are expressed as mean ± SEM (Standard error mean); Values are calculated using one-way ANOVA followed by Dennett’s test; ***indicates P <0.001,
**indicates P <0.01 and *indicates P <0.05 when compared to control; bindicates P <0.01and cindicates P <0.05 when compared to standard drug; n = 5.
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mechanism of action is yet to be discovered. Again in
hot plate test the extract also showed prominent anti-
nociceptive effect against the standard drug ketorolac.
The hot plate response is a more complex supraspin-
ally organized behavior [23]. The μ receptor is a type of
receptor that is commonly known as the pain relief recep-
tor. It has been proved to be a potent receptor in regulat-
ing thermal pain [24]. Moreover, activation of μ2 opioid
subtype receptor leads to spinal analgesia [25]. Therefore,
by considering the test report, it may be assumed that the
antinociceptive activity of L. glutinosa leaves extract is
likely to be mediated centrally although the exact mechan-
ism is yet to be discovered. Previous studies on different
plant extracts showed analgesic effect in animal models
and their effects have been attributed to the presence of
alkaloids, glycosides, flavonoids and saponins [26,27]. The
phytochemical screening of L. glutinosa extract revealed
the presence of most of the above‑mentioned phytochemi-
cals [20]. Thus it is possible that the analgesic activity
of L. glutinosa leaves extract can be due to the presence
of these phytochemical constituents.
The present study was also conducted to evaluate the
probable anti-inflammatory activity of the methanol ex-
tract of L. glutinosa leaves on mice in an acute inflamma-
tory model. The carrageenan‑induced mice paw oedema is
a suitable test for evaluating anti‑inflammatory drugs or
natural products [28]. Carrageenan induced paw edema is
biphasic event. In the first phase there are incidences like
release of histamine, serotonin and kinins whereas the sec-
ond phase of edema is imposed by release of prostaglan-
dins, protease and lysosome. The second phase is sensitive
to most clinically effective anti-inflammatory drugs [29].
The results of present study showed that the role of
methanolic extract of L. glutinosa leaves against carra-
geenan induced acute inflammation was significant. The
leaves extract at a dose of 250 and 500 mg/kg showed sig-
nificant dose dependent reduction in paw size from 1–4 h
and elicited anti‑inflammatory response comparable with
standard drug ketorolac. This might be due to the inhib-
ition of the biphasic response induced by the carrageenan.
Therefore, it is possible that acute anti‑inflammatory effectof L. glutinosa leaves may involve multiple mechanisms like
inhibition of either cyclooxygenase and/or lypooxygenase
enzyme or inhibition of synthesis, release and action of
above inflammatory mediators; but the exact mechanism of
action needs to be discovered by further investigation.
It is known that fever is provoked by many exogenous
substances in animal models, including bacterial endo-
toxins and microbe infection. These exogenous pyrogens
are responsible for the production of different pro-
inflammatory cytokines which stimulate the release of
local prostaglandins (PGs) by entering into the hypothal-
amic circulation and therefore resetting the hypothal-
amic thermal set point. Thus to regulate the body
temperature it is necessary to have a delicate balance be-
tween the production and loss of heat. It is the hypothal-
amus that regulates the set point and also controls body
temperature. The non-steroidal anti-inflammatory drugs
inhibit the prostaglandin synthetase within the hypothal-
amus and thereby demonstrate their antipyretic action
[30]. The present study revealed that the methanolic ex-
tract of L. glutinosa leaves causes a significant antipyretic
effect in yeast provoked elevation of body temperature.
Here, the methanolic extract caused almost similar re-
sult in lowering of body temperature, in comparison to
that of standard drug. It may be predicted that the ex-
tract their antipyretic action through inhibition of pros-
taglandin synthetase within the hypothalamus as like
as the NSAIDs. Although, there is no direct evidence of
L. glutinosa to interfere with prostaglandin synthesis in
hypothalamus but it can be supported by a related study
in which Dalbergia odorifera extract was found to in-
hibit prostaglandin biosynthesis [31]. Thus the present
pharmacological evidence provides support for the folk-
lore claim of L. glutinosa leaves as an antipyretic agent.
Conclusions
In light of the results, it can be revealed that the hydro-
alcoholic extracts of L. glutinosa leaves have remarkable
thrombolytic, analgesic, anti-inflammatory and anti-
pyretic activities. Therefore, it may presage further studies
to better understand the mechanism of such actions
scientifically.
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Plant material collection and identification
For the investigation, the leaves of L. glutinosa were col-
lected by the authors from Potia, Chittagong, Bangladesh
in July 2012. The plant was identified and authenticated
by an expert botanist of Bangladesh National Herbarium
(DACB), Mirpur, Dhaka (Accession No. 38277) and a
voucher specimen was submitted at the herbarium for
future reference.
Extract preparation
Weighed (630 g of the dried and powdered) sample was
soaked in 2200 ml of 99% methanol in clean, sterilized,
and flat-bottomed glass container. Afterwards, it was
sealed and maintained for 15 days accompanying occa-
sional stirring and agitation. The complete mixture was
then subjected to coarse filtration on a piece of clean,
white sterilized cotton material and Whatman® filter
paper. The extract was obtained by evaporation using
rotary evaporator (Bibby RE-200, Sterilin Ltd., UK) at
4 rpm and 65°C temperature. It rendered a gummy con-
centrate of greenish color. The gummy concentrate was
designated as crude extract or methanolic extract. Then the
crude methanolic extract was dried by freeze drier and pre-
served at +4°C (yield 0.79%).The concentrated methanolic
extract was partitioned by modified Kupchan method [32]
and the resultant aqueous soluble partitionates i.e., n-
hexane (yield approx. 19.02%), ethyl acetate (yield approx.
26.54%), and chloroform (yield approx. 6.59%) soluble
fractions were used for the experimental processes.
Chemicals
All the chemicals used in this study were of analytical
grade, and purchased from Sigma Chemical Co. (St. Louis,
MO, USA), and Merck (Darmstadt, Germany). To the
commercially available lyophilized S-Kinase™ (Streptokin-
ase) vial (Batch no: VEH 09, Popular Pharmaceutical Ltd.,
Bangladesh) of 1,500,000 I.U., 5 ml 0.9% sodium chloride
(NaCl) was added and mixed properly. This solution was
used as a stock from which 100 μl (30,000 I.U) was used
for in vitro thrombolysis assay.
Test animals
For the screening of in vivo antipyretic, analgesic, and
anti-inflammatory potential of hydroalcoholic extracts of
L. glutinosa leaves, young Swiss-albino mice (aged 20–25
days) of either sex, average weight 20–25 g were used.
They were collected from the Animal Resources Branch
of ICDDR, B (International Centre for Diarrheal Disease
and Research, Bangladesh). After collection, they were
kept in favorable condition for one week for adaptation
and fed rodent food and water ad libitum formulated by
ICDDR,B. Throughout the experiments, all animals
received human care according to the criteria outlinedin the ‘Guide for the Care and Use of Laboratory Animals’,
8th edition, prepared by the National Academy of Sciences
and published by the National Institute of Health (US).
Thrombolytic assay
In vitro clot lysis activity of the leaves was carried out
according to the method of Prasad et al. [33] with minor
modifications. With ethical considerations, and aseptic
precaution, 7 ml of venous blood was drawn from
healthy volunteers (n = 5) having no history of smoking,
taking lipid lowering drugs, oral contraceptive or anti-
coagulant therapy and transferred to different pre weighed
sterile micro-centrifuge tube (1 ml/tube). The micro-
centrifuged tubes were subjected to incubation at 37°C for
45 min. After the formation of clot, serum was completely
removed from the tubes (carried out without disturbing
the clot formed) and each tube having clot was again
weighed to determine the weight of the clot (clot weight =
weight of clot containing tube – weight of tube alone).
To each micro-centrifuge tube containing pre-weighed
clot, 100 μl solution of different extracts (n-hexane, ethyl
acetate, chloroform and methanolic extract), concentra-
tion 1 mg/mL, were added accordingly. As a positive con-
trol, 100 μl of streptokinase and as a negative non
thrombolytic control, 100 μl of sterilized distilled water
were separately added to the control tubes numbered.
Then all the tubes were incubated again at 37°C for
90 min and observed for clot lysis. After incubation, the
obtained fluid was removed from the tubes and they were
again weighed to observe the difference in weight after
clot disruption. At last, difference obtained in weight was
calculated and the result was expressed as percentage of
clot lysis following the underneath equation.
% of clot lysis ¼ wt: of released clot=clot wt:ð Þ  100
Analgesic activity test
In the current investigation two different methods were
employed for testing the possible peripheral and central an-
algesic effects of L. glutinosa leaves; namely acetic acid in-
duced writhing test and hot plate test in mice respectively.
Hot plate test
The hot plate test was performed following the method
of Asongalem et al. [34]. Pain reflex in response to the
thermal stimulus was measured using a Le7406 hot plate
(Panlab S2, Cornella, Barcelona, Spain). Before 30 min
of the test, mice were placed in ten different groups
comprising six (6) mice in each group and were intra-
gastrically treated in the following manner: group I was
treated with negative control (isotonic saline solution,
0.9%), group II with positive control (ketorolac) as refer-
ence drug (10 mg/kg body weight), and groups III–X
Bhowmick et al. Biological Research 2014, 47:56 Page 7 of 8
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weight. Mice were placed on a 55 ± 1°C hot plate in order
to obtain their response to electrical heat-induced noci-
ceptive pain stimulus judged by the presence of behaviors
such as licking of the fore and hind paws or jumping. The
pain response was measured at 30 min and at every hour
thereafter for 4 h. The cut-off time used to prevent skin
damage was 25 sec.Acetic acid induced writhing test
The analgesic activity of the crude methanolic extract
was studied using acetic acid induced writhing model in
mice [10,35]. The animals were divided into four groups
including control (Group I), positive control (Group II)
and two test groups (Group III-IV). The animals of
group III and IV were administered test substance at the
dose of 250 and 500 mg/kg body weight respectively.
Positive control group received ketorolac (standard
drug) at the dose of 10 mg/kg body weight and vehicle
control group was treated with 1% Tween 80 in distilled
water at the dose of 10 ml/kg body weight. Test samples,
standard drugs and control vehicle were administered
orally 30 min before intraperitoneal administration of
0.7% acetic acid. After 15 min of time interval, the writh-
ing (constriction of abdomen, turning of trunk and ex-
tension of hind legs) was observed on mice for 5 min.Anti-inflammatory activity test
Carrageenan induced mice hind paw edema was used as
the animal model of acute inflammation according to
the method of Lanhers et al. [36]. In this experiment,
the mice were divided into four groups of five animals
each. Group I (control) received 2% Tween 80 in normal
saline (2 ml/kg). Group II (Positive control) received
10 mg/kg body wt. of ketorolac orally. Group III and IV
received 250 and 500 mg/kg body wt. of the extract or-
ally respectively. Acute inflammation was induced in all
the four groups by sub plantar injection of 0.05 ml of its
suspension of Carrageenan with 2% Tween 80 in normal
saline in the right Paw of the mice 30 minutes after the
oral administration of the tested materials. The paw vol-
ume was measured with a micrometer screw gauze at 1, 2,
3 and 4 h after the administration of the drug and the ex-
tract. The percentage inhibition of inflammatory effect of
the extract was calculated using the following expression:
Percentage inhibition of inflammation ¼ Vc‐Vtð Þ=Vc½   100
Where Vc is the average degree of inflammation by the
control group and Vt is the average degree of inflamma-
tion by the test group.Antipyretic activity test
The antipyretic activity was evaluated by Brewer’s yeast in-
duced pyrexia in experimental animal [37]. Hyperpyrexia
was induced by subcutaneous administration of 10 ml/kg
body weight 20% aqueous suspension of brewer’s yeast.
The selected animals were fasted overnight with water ad
libitum before the experiments. Initial rectal temperature
of animals was recorded using an Ellab thermometer
(33.19 ± 0.40°C). After 18 h of subcutaneous administra-
tion, the animals that showed an increase of 0.3–0.5°C in
rectal temperature were selected for the antipyretic activ-
ity. Crude methanolic extract of plant was given orally
(500 mg/kg). Paracetamol (150 mg/kg orally) was used as
reference drug, whereas, control group received distilled
water (10 ml/kg) only. The rectal temperature was re-
corded at 1 h intervals for 3 h after treatment [38].
Statistical analysis
One way ANOVA with Dunnett’s post Hoc test for this
experiment was carried out with SPSS 16.0 for Win-
dows® software and the results obtained were compared
with the control group. P values <0.001 were considered
to be statistically significant.
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